Iron Overload in Pediatric Oncology Patients
Completed
Conditions studied: Iron Overload
In brief
The purpose of this study is to evaluate for iron overload in pediatric oncology and transplant patients who have completed their treatment between one to ten years ago.
Key facts
- Study ID
- NCT01034072
- Run by
- Northwell Health
- People needed
- 75
- Starts
- 2009-12-01
- Expected to finish
- 2012-01-01
- Last updated by the study team
- 2018-04-11
Who can join
Age: 7 and older, up to 25. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients six and a half to twenty five years of age with a history of acute myelogenous leukemia, rhabdomyosarcoma, Ewing sarcoma, osteosarcoma, and neuroblastoma who have completed their treatment or received their last packed red blood cell transfusion at least one year prior to enrollment (which ever occurred later) and are one to ten years post-treatment.
- Patients six and a half to twenty five years of age who have undergone hematopoietic stem cell transplant for any malignancy and are at least one year from their last transfusion or transplant date prior to enrollment (which ever occurred later) and are one to ten years post-transplant.
- Patients who were treated at Schneider Children's Hospital or at Children's Hospital of Philadelphia.
You may not qualify if…
- Patients who have clinical evidence of chronic graft vs. host disease of skin, liver or gastrointestinal tract.
- Patients with a chronic infection (viral hepatitis), liver disease (fibrosis, cirrhosis), or a history of radiation to the liver.
- Patients who cannot have an MRI due to metallic implants (i.e. pacemakers, prosthetic valves, etc.)
- Patients who are pregnant.
Where it is running
- Feinstein Institute for Medical Research — Manhasset, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.